Passive tumor targeting of soluble macromolecules and drug conjugates.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Critical reviews in therapeutic drug carrier systems

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1386002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

  2008cited by this paper
• Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

  2004cited by this paper
• The renal excretion and retention of macromolecules

  2004cited by this paper
• 97Ru-transferrin uptake in tumor and abscess

  2004cited by this paper
• Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes

  2004cited by this paper
• A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat

  2004cited by this paper
• Reduced cardiotoxicity of doxorubicin given in the form ofN-(2-hydroxypropyl) methacrylamide conjugates: an experimental study in the rat

  2004cited by this paper
• Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.

  1991cited by this paper
• N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.

  1991cited by this paper
• Chemoembolism in cancer chemotherapy.

  1991cited by this paper
• Hepatic Disposition Characteristics of Electrically Charged Macromolecules in Rat in Vivo and in the Perfused Liver

  1991cited by this paper
• Synthetic Polymers Conjugated to Monoclonal Antibodies: Vehicles for Tumour-Targeted Drug Delivery

  1991cited by this paper
• The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.

  1991cited by this paper
• Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.

  1991cited by this paper
• Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.

  1990cited by this paper
• Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues.

  1990cited by this paper
• Disposition Characteristics of Macromolecules in Tumor-Bearing Mice

  1990cited by this paper
• Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

  1990cited by this paper
• Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis.

  1990cited by this paper
• Vascular and interstitial barriers to delivery of therapeutic agents in tumors

  1990cited by this paper
• Preparation and properties of a mitomycin C-albumin conjugate.

  1990cited by this paper
• Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran.

  1990cited by this paper
• The pharmacokinetics of polymer-bound adriamycin.

  1990cited by this paper
• Pharmacokinetics of Daunorubicin and Doxorubicin in Plasma and Leukemic Cells from Patients with Acute Nonlymphoblastic Leukemia

  1989cited by this paper
• Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease.

  1989cited by this paper
• Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times.

  1989cited by this paper
• Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.

  1989cited by this paper
• Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

  1989cited by this paper
• Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates.

  1989cited by this paper
• Tumoritropic and lymphotropic principles of macromolecular drugs.

  1989cited by this paper
• Erythrocyte membrane-bound daunorubicin as a delivery system in anticancer treatment.

  1989cited by this paper
• Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model.

  1989cited by this paper
• Doxorubicin-Loaded Nanoparticles: Increased Efficiency in Murine Hepatic Metastases

  1989cited by this paper
• Effect of galactose on interaction of N‐(2‐hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: Preliminary application to an anticancer agent, daunomycin

  1989cited by this paper
• Doxorubicin: effect of different schedules on toxicity and anti-tumor efficacy.

  1989cited by this paper
• Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver.

  1989cited by this paper
• Liposomal sustained-release delivery systems for intravenous injection. III. Antitumor activity of lipophilic mitomycin C prodrug-bearing liposomes.

  1988cited by this paper
• Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody.

  1988cited by this paper
• Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue

  1988cited by this paper
• Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.

  1988cited by this paper
• Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

  1988cited by this paper
• Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.

  1988cited by this paper
• Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

  1988cited by this paper
• Transport of molecules in the tumor interstitium: a review.

  1987cited by this paper
• Disposition characteristics of mitomycin C-dextran conjugate in normal and tumor-bearing muscles of rabbits.

  1987cited by this paper
• Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38.

  1987cited by this paper
• Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.

  1987cited by this paper
• Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.

  1987cited by this paper
• Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.

  1987cited by this paper
• Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.

  1987cited by this paper
• Continuous Infusion or Intravenous Bolus: What Is the Rationale for Doxorubicin Administration?

  1987cited by this paper
• Nanoparticles in drug delivery.

  1987cited by this paper
• [Targeting of anthracyclines and hepatomas].

  1987cited by this paper
• Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes

  1987cited by this paper
• Preparation and evaluation in vitro and in vivo of fibrinogen microspheres containing adriamycin.

  1986cited by this paper
• Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells.

  1986cited by this paper
• Differential macromolecular leakage from the vasculature of tumors

  1986cited by this paper
• Microvascular permeability of normal and neoplastic tissues.

  1986cited by this paper
• A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

  1986cited by this paper
• Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.

  1986cited by this paper
• In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.

  1986cited by this paper
• Characterization of liposomes and an emulsion containing mitomycin C or lipophilic mitomycin C prodrugs.

  1986cited by this paper
• A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

  1986cited by this paper
• Plasma disposition and in vivo and in vitro antitumor activities of mitomycin C-dextran conjugate in relation to the mode of action.

  1985cited by this paper
• Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate.

  1985cited by this paper
• Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug.

  1985cited by this paper
• Is there evidence for venular large junctional gap formation in inflammation?

  1985cited by this paper
• Controlled Release of Drug Model from N‐(2‐Hydroxypropyl)‐methacrylamide Copolymers

  1985cited by this paper
• Passage of uncharged dextrans from blood to lung lymph in awake sheep.

  1985cited by this paper
• Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity.

  1984cited by this paper
• Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.

  1984cited by this paper
• Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.

  1984cited by this paper
• Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers.

  1984cited by this paper
• Targeting of daunorubicin by association with DNA or proteins: a review.

  1984cited by this paper
• Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat.

  1984cited by this paper
• Extravascular diffusion in normal and neoplastic tissues.

  1984cited by this paper
• Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes.

  1983cited by this paper
• A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

  1983cited by this paper
• Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues.

  1983cited by this paper
• Quantitative autoradiographic measurements of blood-brain barrier permeability in the rat glioma model.

  1982cited by this paper
• PERMEABILITY OF PULMONARY ENDOTHELIUM TO NEUTRAL AND CHARGED MACROMOLECULES *

  1982cited by this paper
• In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.

  1982cited by this paper
• Vascular permeability to macromolecules in rabbit paw and skeletal muscle: a lymphatic study with a mathematical interpretation of transport processes.

  1982cited by this paper
• Physico-chemical and antitumor characteristics of high molecular weight prodrugs of mitomycin C.

  1982cited by this paper
• Glomerular permeability to neutral and anionic dextrans in experimental diabetes.

  1982cited by this paper
• Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes.

  1982cited by this paper
• Antitumor activity of mitomycin C-dextran conjugate against various murine tumors.

  1981cited by this paper
• Review. Endothelial vesicles.

  1981cited by this paper
• Transport pathways in capillaries--in search of pores.

  1980cited by this paper
• Theoretical model for glomerular filtration of charged solutes.

  1980cited by this paper
• Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin.

  1980cited by this paper
• DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.

  1980cited by this paper
• Action of histamine on the mesenteric microvasculature.

  1980cited by this paper
• Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall

  1979cited by this paper
• Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

  1979cited by this paper
• Transcapillary passage of albumin, effects of tissue cooling and of increases in filtration and plasma colloid osmotic pressure.

  1979cited by this paper
• Glomerular permeability of macromolecules. Effect of molecular configuration on the fractional clearance of uncharged dextran and neutral horseradish peroxidase in the rat.

  1979cited by this paper
• Studies on the capillary permeability of experimental liver metastases.

  1978cited by this paper
• Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations.

  1978cited by this paper
• Rat alpha 1-acid glycoprotein: uptake by inflammatory and tumour tissues.

  1978cited by this paper

• IgM has a better relative distribution in inflammation sites and tumor tissues than IgG

  2025cites this paper
• Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis

  2022cites this paper
• The cell type dependent sorting of CD9- and CD81 to extracellular vesicles can be exploited to convey tumor sensitive cargo to target cells

  2022cites this paper
• Effect of a Drug Delivery System Made of Quercetin Formulated into PEGylation Liposomes on Cervical Carcinoma In Vitro and In Vivo

  2021cites this paper
• Herbal Nanocarriers for Cancer Therapy

  2020cites this paper
• Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview.

  2020cites this paper
• Mechanisms of nanoparticle formation and gene delivery of polyplex-based delivery systems

  2020cites this paper
• Investigating the Accumulation of Submicron Phase-Change Droplets in Tumors.

  2020cites this paper
• Targeted double domain nanoplex based on galactosylated polyethylenimine enhanced the delivery of IL‐12 plasmid

  2020cites this paper
• Practical Application of Periostin as a Biomarker for Pathological Conditions.

  2019cites this paper
• IR780 loaded perfluorohexane nanodroplets for efficient sonodynamic effect induced by short-pulsed focused ultrasound.

  2019cites this paper
• Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies.

  2019cites this paper
• Nano Drugs

  2019cites this paper
• An Open-Label, I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, and Preliminary in with

  2019cites this paper
• TOWARDS THE RATIONAL DESIGN AND APPLICATION OF POLYMERS FOR GENE THERAPY: INTERNALIZATION AND INTRACELLULAR FATE

  2019cites this paper
• Bacteriophage Fusion Peptides Based Targeted Delivery of Therapeutics to Cancer Cells

  2018cites this paper
• Saccharide-based nanocarriers for targeted therapeutic and diagnostic applications

  2018cites this paper
• Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography

  2018cites this paper
• Programming of Retention Capacity and Release Capabilities of Propargyl Acrylate Nanoparticles Decorated with Poloxamer Copolymer

  2018cites this paper
• An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma

  2018cites this paper
• Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

  2018cites this paper
• Efficient and controllable thermal ablation induced by short-pulsed HIFU sequence assisted with perfluorohexane nanodroplets.

  2018cites this paper
• Improving the Efficacy of Anticancer Drugs via Encapsulation and Acoustic Release.

  2018cites this paper
• Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?

  2018cites this paper
• Piloting Your Nanovehicle to Overcome Biological Barriers.

  2017cites this paper
• 1.29 Electroactive Polymeric Biomaterials

  2017cites this paper
• Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.

  2017cites this paper
• Oscillating magnet array-based nanomagnetic gene transfection of mammalian cells relevant to regenerative medicine

  2017cites this paper
• Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy

  2017cites this paper
• Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview

  2017cites this paper
• Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy

  2016cites this paper
• Multifunctional Magnetic Liposomes for Cancer Imaging and Therapeutic Applications

  2016cites this paper
• Nanoparticle-tissue interaction

  2016cites this paper
• MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.

  2016cites this paper
• Determinants of Nanomedicine Performance for the Treatment of Solid Tumors: Whole Tumor and Intratumoral Assessment of Liposome Distribution

  2016cites this paper
• Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line

  2016cites this paper
• Under Pressure: Elevated Blood Pressure Enhances Targeting of Tumors by Oncolytic Viruses.

  2016cites this paper
• Disorders of Vascular Permeability.

  2016cites this paper
• Parenteral Routes for Drug Delivery and Targeting

  2016cites this paper
• Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.

  2016cites this paper
• Original article: SHORT-INTERFERENCE RNAS: BECOMING MEDICINES

  2015cites this paper
• Factors affecting ultrasonic release from eLiposomes.

  2015cites this paper
• Macromolecular and Inorganic Nanomaterials Scaffolds for Carbon Monoxide Delivery: Recent Developments and Future Trends.

  2015cites this paper
• Preparation and study on anti-tumor effect of chitosan-coated oleanolic acid liposomes

  2015cites this paper
• Opportunities and challenges for utilization of nanoparticles as bioactive drug carriers for the targeted treatment of cancer

  2015cites this paper
• Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats

  2015cites this paper
• Short-interference RNAs: becoming medicines

  2015cites this paper
• Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging

  2015cites this paper
• Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity

  2015cites this paper
• Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model.

  2015cites this paper
• EPR: Evidence and fallacy.

  2014cites this paper
• Polyester Dendrimers: Smart Carriers for Drug Delivery

  2014influential citation
• Feasibility Study on the Use of Gold Nanoparticles as a Dose Enhancement Agent for a Superficial X-ray Therapy Applied to Melanoma

  2014cites this paper
• The in vitro and in vivo toxicity of graphene quantum dots.

  2014cites this paper
• Phase transitions of perfluorocarbon nanoemulsion induced with ultrasound: a mathematical model.

  2014cites this paper
• Potentiating antilymphoma efficacy of chemotherapy using a liposome for integration of CD20 targeting, ultra-violet irradiation polymerizing, and controlled drug delivery

  2014cites this paper
• Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer

  2014cites this paper
• Paclitaxel Nanoparticles - An Approach to Improve the Bioavailability

  2014cites this paper
• Nanoparticulate systems as drug carriers: the need

  2014cites this paper
• Évaluation de l'efficacité des nanoparticules chitosane-siARN à inhiber, in vitro, l'expression du gène MDR1 responsable de la résistance à la chimiothérapie

  2014cites this paper
• Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology

  2014cites this paper
• Mannosylated Chitosan Nanoparticles for Delivery of Antisense Oligonucleotides for Macrophage Targeting

  2014cites this paper
• Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin

  2014cites this paper
• The Effects of oil-in-Water Nanoemulsion Polyethylene Glycol Surface Density on Intracellular Stability, Pharmacokinetics, and Biodistribution in Tumor Bearing Mice

  2014cites this paper
• Biological interfacial engineering for metastatic cancer diagnosis and intervention.

  2014cites this paper
• Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery

  2014cites this paper
• Proteases as activators for cytotoxic prodrugs in antitumor therapy.

  2014cites this paper
• Mechanisms for targeted delivery of nanoparticles in cancer.

  2013cites this paper
• Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy

  2013cites this paper
• Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy.

  2013cites this paper
• From Biocompatible to Biodegradable: Poly(Ethylene Glycol)s with Predetermined Breaking Points

  2013cites this paper
• Preparation and properties of acid-cleavable poly(vinyl alcohol)cis-aconityl-antitumor anthracycline conjugates

  2013cites this paper
• Micro/Nanospheres for Gene Drug Delivery

  2013cites this paper
• Universal concept for the implementation of a single cleavable unit at tunable position in functional poly(ethylene glycol)s.

  2013cites this paper
• TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology

  2013cites this paper
• Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd2O3–DEG for molecular MRI

  2013influential citation
• Systemic delivery of phosphorylated nucleoside analogues and siRNA via LCP nanoparticles for cancer therapy

  2013cites this paper
• Intravenous magnetic nanoparticle cancer hyperthermia

  2013cites this paper
• Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules).

  2013cites this paper
• Cancer Gene Therapy: Targeted Genomedicines

  2013cites this paper
• Transarterial chemoembolization of hepatocellular carcinoma – agents and drugs: an overview. Part 2

  2013cites this paper
• Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.

  2013cites this paper
• Naturally occurring canine osteosarcoma in the dog animal model for research of targeted radiotherapy using beta-emitting radioisotopes with various ligands

  2013cites this paper
• Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.

  2013cites this paper
• Significance and strategies in developing delivery systems for bio-macromolecular drugs

  2013cites this paper
• Dosetaksel İçeren Nanopartiküllerin Formülasyonu ve in Vitro Değerlendirilmesi

  2013cites this paper
• The Role of RNA Interference in Targeting the Cancer Stem Cell and Clinical Trials for Cancer

  2012cites this paper
• Formation of eLiposomes as a drug delivery vehicle.

  2012cites this paper
• Radiopharmaceuticals for Bone Metastasis Therapy and Beyond: A Voyage from the Past to the Present and a Look to the Future

  2012cites this paper
• Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

  2012cites this paper
• IN-VITRO CYTOTOXICITY ANALYSIS OF TAMOXIFEN CITRATE LOADED CROSS-LINKED GUAR GUM NANOPARTICLES ON JURKAT (HUMAN T-CELL LEUKEMIA) CELL LINE

  2012cites this paper
• In vivo gene delivery by nonviral vectors: overcoming hurdles?

  2012cites this paper
• Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery

  2012cites this paper
• Application of targeted contrast nanoparticles for human multiple myeloma imaging

  2012cites this paper
• Ultrasound-enhanced drug delivery for cancer

  2012influential citation
• Phase transitions of nanoemulsions using ultrasound: experimental observations.

  2012cites this paper
• June . , Vol . 3 ( 2 ) Applications of Dendrimers in Cancer Therapy

  2012cites this paper
• Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

  2012cites this paper
• Antitumoural hydroxyapatite nanoparticles‐mediated hepatoma‐targeted trans‐arterial embolization gene therapy: in vitro and in vivo studies

  2012cites this paper
• Ultrasound-induced calcein release from eLiposomes.

  2012cites this paper